J. Yang, M. T. Jacobsen, H. Pan, J. Kopecˇek
Canada). Side-chain protected Fmoc-amino acids, 2-chlorotrityl
resin, and 2-(7-aza-1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluro-
nium hexafluorophosphate (HATU) were purchased from AAPPTec
(Louisville, KY). Piperidine (PIP; 99.5þ%, Biotech grade), triisopro-
pylsilane (TIS; 99%), papain (EC 3.4.22.2), glutathione, 5-hexynoic
acid, Bz-Phe-Val-Arg-NAp (chromogenic substrate), iodoacetic acid
sodium salt, CuBr, L-ascorbic acid, and O-phthaladehyde (OPA)/
3-mercaptopropionic acid (MPA) were purchased from Sigma–
Aldrich (St. Louis, MO, USA). Ethyldiisopropylamine (DIPEA; 99%)
was from Alfa Aesar (Ward Hill, MA, USA). Diethyl ether and
dichloromethane (DCM) were purchased from Mallinckrodt Baker
(Phillipsburg, NJ, USA). Trifluoroacetic acid (TFA; 99%) was
purchased from Acros Organics (Morris Plains, NJ, USA). Surfactant
free fluorescent yellow–green amidine modified polystyrene (PS)
beads were from Interfacial Dynamics Corp. (Portland, OR).
in p-nitrophenoxy groups) with oligopeptide-containing
diamines.[10] Thedegradabilityofhydrogelswasdependent
on the length and detailed structure of the oligopeptide
sequence and on the equilibrium degree of swelling
(network density); the higher the degree of swelling, the
faster the rate of degradation. The degree of swelling also
has an impact on surface versus bulk degradation of the
hydrogel. If the enzyme cannot diffuse into the hydrogel
interior, only surface degradation takes place.[11] Similar
HPMA-based hydrogels degradable by cathepsin B, a
lysosomal thiol proteinase, have also been evaluated.[12]
In further experiments, HPMA-based hydrogels with
degradable crosslinks were shown to release FITC-dextran
and daunomycin (covalently bound via oligopeptide
spacer) during incubation with a mixture of lysosomal
enzymes (Tritosomes) or chymotrypsin.[13] Recently, Plun-
kett et al. studied acrylamide-based hydrogels containing
oligopeptides degradable by chymotrypsin.[14]
Synthesis of Enzyme-Degradable Peptides with
Dialkyne Modification
Thefunctionalized peptides, flankedby alkynegroups atbothends,
were synthesized using solid-phase methodology and manual
Fmoc/tBu strategy on 2-chlorotrityl resin. As an example, the
synthesis of GFLG1 is shown in Scheme 1. Fmoc-Lys(ivDde)ꢀOH
was employed as the first amino acid residue to introduce two free
amine groups. The protecting groups (Fmoc- and ivDde-) were
removed selectively; one was used to introduce alkyne group into
the C-terminus of the peptide, whereas the other functioned in
constructing the peptide sequence. Incorporation of alkyne at the
N-terminus was accomplished by acylation of the peptide with
5-hexynoic acid using the standard coupling protocol (ꢀCOOH/
DIPEA/HATU in DMF). The resin was then washed sequentially
with 3 ꢁ DMF, 3 ꢁ DCM, and 3 ꢁ MeOH, and dried under vacuum.
The resulting resin-bound peptides were cleaved from the resin,
and side-chains were deprotected using TFA/H2O/TIS (95:2.5:2.5)
cocktail. Crude peptides were purified by RP-HPLC (Agilent
Technologies 1100, semipreparative Zorbax 300SB-C18 column,
Poly(ethylene glycol) (PEG) is a hydrophilic polymer that
has been used in several clinical applications. PEG-based
hydrogelshavebeenextensivelystudied.Hubbell’slaboratory
used multiarm-PEG and Michael-type addition to synthesize
extracellular matrix mimicking hydrogels degradable by cell-
excretedmatrixmetalloproteinases.[9,15] PEG-basedhydrogels
containing Schiff base linkages were designed for low
molecular weight (doxorubicin) drug delivery.[16] Azide-
alkyne click chemistry was also used for the synthesis of
PEG-based hydrogels.[6,17] Hawker and coworkers[6] synthe-
sized hydrogels by reacting a tetraazide-modified tetraethy-
lene glycol with telechelic alkyne terminated PEGs of varying
molecular weight. Yang and coworkers employed 4-arm
alkyne terminated PEG and crosslinked it with a series of RGD
containing dialkyne-peptides. However, both alkyne groups
were attached to the N-terminal lysine. Consequently, the
side-chains were degradable, but the hydrogel crosslinked
backbone remained stable.[17]
˚
250 mm ꢁ 9.4 mm, 300 A pore size, 5 mm particle size, flow rate
2.5 mL ꢂ minꢀ1) employing a gradient from 50 to 100% B over
30 min,wherebufferAwas0.1%TFAinwaterandbufferB0.1%TFA
in 90:10 v/v methanol/water. The purity of peptides GFLG1 and
GFLG2 was verified by analytical RP-HPLC (Figure S1 and S2 of
Supporting Information). Peptide structures were ascertained by
MALDI-TOF mass spectrometry (Voyager-DE STR Biospectrometry
Workstation, Perseptive Biosystems) (Figure S3 and S4 of Support-
ing Information). For GFLG2, Fmoc-Lys(Fmoc)-OH was used as the
first amino acid to incorporate a branched structure after removal
of Fmoc-group. The end-modification was realized by acylation of
the peptide with 5-hexynoic acid. The molecular structures of the
two peptides are shown in Table 1.
In this study we synthesized two 4-arm azide-terminated
PEGs differing in molecular weight (2 100 and 8 800) and
two alkyne-terminated peptides, [alkyne]-GFLGK-[alkyne]
(GFLG1) and ([alkyne]-GFLG)2K (GFLG2). The hydrogels were
synthesized by Huisgen cycloaddition (click chemistry) of PEG
azides with peptide alkynes and contained enzymatically
degradablecrosslinks. Thekineticsofthecrosslinkingreaction
was monitored by dynamic rheology. The hydrogels were
characterized by the equilibrium degree of swelling, their
morphology, and bulk and micro-rheology. The relationship
betweenthestructureofthehydrogelsandtheirdegradability
by papain, a thiol proteinase, was also evaluated.
Synthesis of Azido-Terminated Poly(ethylene glycol)
(PEG)
Experimental Part
Thesyntheticprocedureconsistedoftwosteps(Scheme2A):4-arm-
PEG-OH (PEG-4OH) was first transformed into an active inter-
mediate(mesylate-terminatedPEG), followedbyreplacementwith
azido functional group. A typical procedure for synthesis of 4-arm
PEG-N3 with Mn 8 800 g ꢂ molꢀ1 (PEG-4N3 8 800) is briefly described.
Materials
Four-armPEGterminatedwithhydroxygroups(PEG-4OH2 100and
PEG-4OH 8 800) was purchased from Polymer Source (Montreal,
Macromol. Biosci. 2010, 10, 445–454
446
ß 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
DOI: 10.1002/mabi.200900295